Navigation Links
Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial

Columbus, OH (PRWEB) July 13, 2014

Wright & Schulte LLC has learned that the first Lipitor bellwether trial has been scheduled in July of 2015, in U.S. District Court, District of South Carolina. The Lipitor lawsuits are in the discovery process in the South Carolina federal court where District Judge Richard M. Gergel is presiding over the multidistrict litigation (MDL). The complaints pending in the Louisiana court were filed on behalf of individuals who allege that they took the statin medication to lower their cholesterol and developed Type 2 diabetes. As of June 16, there are 846 Lipitor lawsuits pending in MDL No. 2502. These lawsuits further contend that Pfizer Inc., which manufactures Lipitor, either knew about the link between taking the cholesterol lowering drug and developing diabetes or should have known and failed to properly warn consumers of potential Lipitor side-effects. (In Re: Lipitor (atorvastatin calcium) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2502)

The firm has spoke with numerous people regarding Lipitor lawsuits and their belief that they developed Type 2 Diabetes from the Cholesterol lowing statin. If you have experienced side-effects from using Lipitor contact the attorneys at Wright & Schulte for a free legal consultation by calling 1-800-399-0795 or visit You can also Like us on Facebook and Follow us on Twitter for all the latest news on Lipitor and other drug side-effects.

In February 2012, the U.S. Food & Drug Administration (FDA) issued a warning regarding the potential for Lipitor to cause new-onset diabetes. The FDA also ordered Pfizer to change the label on Lipitor to reflect that individuals using the drug risk developing diabetes. Court records show that despite this change, plaintiffs allege that the warnings added to the Lipitor label remain inadequate. [, FDA, February 28, 2012]

A study published in the January 2012 issue of JAMA Internal Medicine suggested that post-menopausal women treated with statins, like Lipitor, may be at higher risk of developing new-onset diabetes. The following year, the British Medical Journal published a study that found patients who take Lipitor, or atorvastatin, faced a 22 percent increase in the risk of new-onset diabetes. A more recent study was published in the British Medical Journal that looked at data of nearly 137,000 patients from Canada, the U.S. and the UK, all of whom had been prescribed statins after they were hospitalized for a stroke, heart attack, or other cardiovascular problem between 1997 and 2011. Some 3,600 of those patients were diagnosed with Type 2 diabetes within two years of starting treatment, according to the study.
[, JAMA Internal Medicine, January 23, 2012]
[, May 29, 2014]

Lipitor, also marketing as atorvastatin, is a statin drug used to lower the risk of heart attack stroke, and chest pain, in individuals with high levels of Low Density Lipoprotein cholesterol, or "bad cholesterol." The statin drug lowers cholesterol by blocking an enzyme in the liver.
[, February 28, 2012]

Court documents indicate that Pfizer is scheduled to begin taking depositions on August 1 of six fact witnesses, including plaintiffs, their spouse or immediate family member, or a plaintiff's health care provider who prescribed Lipitor. At the same time, Pfizer will identify two sales representatives for the plaintiffs to depose. The plaintiffs and Pfizer are to complete their depositions by October 24. A schedule for the MDL proceeding also shows that on December 15, the court will randomly select one of the remaining cases in discovery for the first jury trial scheduled on or before July 1, 2015.
[, May 22, 2014]

As of June 16, there are 846 Lipitor lawsuits pending in the Lipitor litigation. An MDL for Lipitor lawsuits was established earlier this year by transferring all federally filed complaints regarding the medication to the federal district court in South Carolina (MDL No. 2502). The judicial panel centralized the Lipitor complaints because they all involve common questions of fact and allege that the plaintiffs developed type 2 diabetes after using Pfizer’s cholesterol-lowering drug.

About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free Lipitor lawsuit case evaluations are available through or by calling 1-800-399-0795.

Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
Like us on Facebook
Follow us on Twitter
Join us on Google+

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Lipitor Lawsuit News: Pfizer, Inc. Named in Whistleblower Lawsuit Alleging Improper Marketing of Lipitor, Bernstein Liebhard LLP Reports
2. As Lipitor Lawsuits Mount, Bernstein Liebhard LLP Notes Publication of New Study with Possible Explanation for Link between Statins and Diabetes
3. Lipitor Lawsuit News: Bernstein Liebhard LLP Notes Criticism of New Statin Guidelines That Could Result in Millions of New Lipitor Prescriptions
4. New Lipitor Diabetes Lawsuit Alleges Statin Drug Caused Woman to Develop Type 2 Diabetes, Learns Wright & Schulte LLC
5. Lipitor Lawsuits Continue to Mount, as Bernstein Liebhard LLP Notes Filing of New Claim Alleging an Association Between Lipitor and Diabetes
6. Dozens of Lipitor Lawsuits Involving Diabetes Allegations Moved to Federal Court, Bernstein Liebhard LLP Reports
7. Warning of Statin Drug Lipitor’s Risk of Type 2 Diabetes Came Too Late Say Patients Filing Lipitor Lawsuits
8. Lipitor Lawsuit News: Judicial Panel Denies Consolidation of Federal Cases, Rottenstein Law Group LLP Reports
9. Lipitor Lawsuit Website Launched by Bernstein Liebhard LLP to Provide Information to the Public Regarding Lipitor Side Effects, Ongoing Litigation
10. National Law Firm Baron and Budd Helping Women with Alleged Injuries from Lipitor Use Understand the Lipitor Lawsuit
11. National Law Firm Baron and Budd Responds to Disproportionate Harm Brought to Women Using Lipitor, According to Study
Post Your Comments:
(Date:11/27/2015)... ... 2015 , ... An inventor, from Hopkinsville, Ky., thought there ... home, so he invented the patent-pending ELECTRONIC M.D. , The ELECTRONIC M.D. provides ... so, it could help to prevent potential overdose situations. As a result, it ...
(Date:11/27/2015)... ... November 27, 2015 , ... The print component of “Supporting ... Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation of approximately 250,000 ... through a vast social media strategy and across a network of top news ...
(Date:11/27/2015)... Fairfax, VVA (PRWEB) , ... November 27, 2015 ... ... (RBMA) motto of progress through sharing, the 2016 Building Better Radiology ... campaigns. The conference will begin on Sunday, March 6, 2016, at Caesars Palace ...
(Date:11/27/2015)... ... November 27, 2015 , ... The ... prided itself for not only fulfilling the needs of advisers and clients but ... affordable price and providing top-tier customer service. However, there's always room for improvement, ...
(Date:11/27/2015)... IL (PRWEB) , ... November 27, 2015 , ... ... of the largest, most successful and prominent nonprofit healthcare organizations in the country. ... governance involvement with various organizations, and helped advance the healthcare industry as a ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... India , November 27, ... --> --> ... personal emergency response system (PERS) ... steadily for 5 years with ... region expected to see a ...
(Date:11/26/2015)... , Nederland, November 26, 2015 /PRNewswire/ ... --> Een nieuwe aanpak combineert immunotherapie ... gevorderde kanker. ) ... -->      (Photo: ... het Leids Universitair Medisch Centrum (LUMC) ...
(Date:11/26/2015)... Research and Markets ( ) ... Future Horizons and Growth Strategies in the Japanese ... Segment Forecasts, Competitive Intelligence, Emerging Opportunities" report ... --> This new 247-page report ... drug monitoring market, including emerging tests, technologies, instrumentation, ...
Breaking Medicine Technology: